Sequential brentuximab vedotin (Bv) before and after adriamycin, vinblastine, and dacarbazine (Bv-AVD) for older patients with untreated classical Hodgkin lymphoma (cHL): Final results from a multicenter phase II study Meeting Abstract
| Authors: | Evens, A. M.; Advani, R. H.; Fanale, M. A.; Smith, S. M.; Helenowski, I.; Jovanovic, B.; Bociek, R. G.; Klein, A.; Winter, J. N.; Gordon, L. I.; Hamlin, P. A. |
| Abstract Title: | Sequential brentuximab vedotin (Bv) before and after adriamycin, vinblastine, and dacarbazine (Bv-AVD) for older patients with untreated classical Hodgkin lymphoma (cHL): Final results from a multicenter phase II study |
| Meeting Title: | 59th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 130 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2017 Dec 9-12 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2017-12-07 |
| Language: | English |
| ACCESSION: | WOS:000432419401380 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V130.Suppl_1.733.733 |
| Notes: | Meeting Abstract: 733 -- Source: Wos |
